USDA’s actions on gene-edited approvals challenged in court
By Jacqui Fatka,
Farm Progress
| 08. 06. 2021
Center for Food Safety’s federal lawsuit says the exemptions for broad categories of GE crops are risky.
Photo licensed for use by CC BY 2.0 on Wikimedia Commons
In May 2020, the previous administration’s USDA issued its final rule to modernize agricultural biotechnology regulations. Of note was revised regulations for evaluating new technologies developed using gene editing. Now environmental groups have challenged the decision to eliminate some of the regulatory requirements for genetically engineered organisms including future GE crops, trees and grasses.
Under the previous regulations, the Animal Plant Health Inspection Service assessed the plant pest risk of each plant transformation event (also sometimes referred to as the individual transformed line, transgenic line, or genetically-engineered line) separately, even though the inserted genetic material may have been identical or very similar to transformation events already assessed. This has sometimes been referred to as an “event-by-event” approach.
Under the revised regulations, developers have the option of requesting a permit or a regulatory status review of a plant developed using genetic engineering that has not been previously evaluated and determined to be nonregulated. This process replaces the petition process in the previous regulations.
In announcing the rule, USDA says the final rule...
Related Articles
By Jonathan Matthews, GMWatch | 12.11.2025
In our first article in this series, we investigated the dark PR tactics that have accompanied Colossal Bioscience’s de-extinction disinformation campaign, in which transgenic cloned grey wolves have been showcased to the world as resurrected dire wolves – a...
By Jessica Hamzelou, MIT Technology Review | 11.07.2025
This week, we heard that Tom Brady had his dog cloned. The former quarterback revealed that his Junie is actually a clone of Lua, a pit bull mix that died in 2023.
Brady’s announcement follows those of celebrities like Paris...
By Lauran Neergaard, AP News | 11.03.2025
WASHINGTON (AP) — The first clinical trial is getting underway to see if transplanting pig kidneys into people might really save lives.
United Therapeutics, a producer of gene-edited pig kidneys, announced Monday that the study’s initial transplant was performed successfully...
By Meagan Parrish, PharmaVoice | 10.10.2025
When CEO Ben Lamm steps into the spotlight, it’s usually to talk about his efforts bringing extinct animals back to life. Once a far-flung idea, Lamm and the company he heads, Colossal Biosciences, have proven they can pull it off...